{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:25Z","timestamp":1786980565438,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:00Z","timestamp":1661040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:00:00Z","timestamp":1661040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10151-022-02678-x","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T04:02:46Z","timestamp":1661054566000},"page":"805-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management of perianal fistulas in Crohn\u2019s disease: a 2021 update of the French National Society of Coloproctology consensus"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-8545","authenticated-orcid":false,"given":"D.","family":"Bouchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"de Parades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Staumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Siproudhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Members of the SNFCP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"de Parades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Staumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Siproudhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tracanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fathallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Babin-Pigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Members of the GETAID","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bouguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Laharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Panis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Roblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zerbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,21]]},"reference":[{"key":"2678_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10151-018-1906-y","volume":"22","author":"D Bouchard","year":"2018","unstructured":"Bouchard D, Pigot F, Staumont G, Siproudhis L, Abramowitz L, Benfredj P et al (2018) Management of anoperineal lesions in Crohn\u2019s disease: a French National Society of Coloproctology national consensus. Tech Coloproctol 22:905\u2013917","journal-title":"Tech Coloproctol"},{"issue":"Suppl2","key":"2678_CR2","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1016\/S1873-9946(12)60502-9","volume":"6","author":"D Hommes","year":"2012","unstructured":"Hommes D, Colombel JF, Emery P, Greco M, Sandborn WJ (2012) Changing Crohn\u2019s disease management: need for new goals and indices to prevent disability and improve quality of life. J Crohns Colitis 6(Suppl2):S224\u2013S234","journal-title":"J Crohns Colitis"},{"key":"2678_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine EJ (1995) Usual therapy improves perianal Crohn\u2019s disease as measured by a new disease activity index McMaster IBD Study Group. J Clin Gastroenterol 20:27\u201332","journal-title":"J Clin Gastroenterol"},{"key":"2678_CR4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA et al (1999) Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 340:1398\u20131405","journal-title":"N Engl J Med"},{"key":"2678_CR5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised double-blind controlled trial. Lancet 388:1281\u20131290","journal-title":"Lancet"},{"key":"2678_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2036.2009.04027.x","volume":"30","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Diamond RH, Wagner CL, Fasanmade AA, Olson AD, Marano CW et al (2009) Benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials. Alimentary Pharmacol Therap 30:210\u2013226","journal-title":"Alimentary Pharmacol Therap"},{"key":"2678_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","volume":"11","author":"G Bouguen","year":"2013","unstructured":"Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF et al (2013) Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab. Clin Gastroenterol Hepatol 11:975\u2013981","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2678_CR8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.crohns.2014.07.003","volume":"8","author":"U Kopylov","year":"2014","unstructured":"Kopylov U, Al-Taweel T, Yaghoobi M, Nauche B, Bitton A, Lakatos PL et al (2014) Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn\u2019s disease: a systematic review and meta-analysis. J Crohns Colitis 8:1632\u20131641","journal-title":"J Crohns Colitis"},{"key":"2678_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/apt.13838","volume":"45","author":"JF Colombel","year":"2017","unstructured":"Colombel JF, Jharap B, Sandborn WJ, Feagan B, Peyrin-Biroulet L, Eichner SF et al (2017) Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn\u2019s disease or ulcerative colitis who had failed conventional therapy. Aliment Pharmacol Ther 45:50\u201362","journal-title":"Aliment Pharmacol Ther"},{"key":"2678_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","volume":"149","author":"I Molendijk","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G et al (2015) Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 149:918\u2013927","journal-title":"Gastroenterology"},{"key":"2678_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/j.gastro.2014.08.003","volume":"148","author":"BG Levesque","year":"2015","unstructured":"Levesque BG, Sandborn WJ, Ruel J, Feagan BG, Sands BE, Colombel JF (2015) Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology 148:37\u201351","journal-title":"Gastroenterology"},{"key":"2678_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-315503","volume":"68","author":"K Sahnan","year":"2019","unstructured":"Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N, McNair AGK et al (2019) Developing a core outcome set for fistulising perianal Crohn\u2019s disease. Gut 68:226\u2013238","journal-title":"Gut"},{"key":"2678_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ibd\/izz200","volume":"26","author":"A Malian","year":"2020","unstructured":"Malian A, Rivi\u00e8re P, Bouchard D, Pigot F, El\u00e9ouet-Kaplan M, Favreau-Weltzer C et al (2020) Predictors of perianal fistula relapse in Crohn\u2019s disease. Inflamm Bowel Dis 26:926\u2013931","journal-title":"Inflamm Bowel Dis"},{"key":"2678_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","volume":"4","author":"NA Kennedy","year":"2019","unstructured":"Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ et al (2019) UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol 4:341\u2013353","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2678_CR15","first-page":"549","volume":"11","author":"Y Davidov","year":"2017","unstructured":"Davidov Y, Ungar B, Bar-Yoseph H, Carter D, Haj-Natour O, Yavzori M et al (2017) Association of induction infliximab levels with clinical response in perianal Crohn\u2019s disease. J Crohns Colitis 11:549\u2013555","journal-title":"J Crohns Colitis"},{"key":"2678_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/apt.13970","volume":"45","author":"AJ Yarur","year":"2017","unstructured":"Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D et al (2017) Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn\u2019s disease. Aliment Pharmacol Ther 45:933\u2013940","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-022-02678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-022-02678-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-022-02678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:28:33Z","timestamp":1662640113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-022-02678-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,21]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1007\/s10151-022-02678-x","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,21]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DB: Takeda as consultant, Abbvie Janssen Takeda for learning. LS: Takeda Abbvie Janssen MSD for clinical research, Takeda as consultant, Takeda Abbvie Janssen Amgen Ferring for learning. VdP: Takeda as consultant, Abbvie, Amgen, Tillots\u00a0for learning. GS: Takeda, Janssen as consultant, Abbvie, Takeda for learning. LA: Abbvie, Takeda, Celltrion for clinical research, Takeda as consultant, Takeda, Abbvie, Janssen, Ferring for learning. FP: Abbvie, Takeda for learning.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}